RT Journal Article
SR Electronic
T1 Phase 3 results for vosaroxin/cytarabine in the subset of patients ≥60 years old with refractory/early relapsed acute myeloid leukemia
JF Haematologica
JO Haematologica
FD Ferrata Storti Foundation
SP e514
OP e518
DO 10.3324/haematol.2018.191361
VO 103
IS 11
A1 Ravandi, Farhad
A1 Ritchie, Ellen K.
A1 Sayar, Hamid
A1 Lancet, Jeffrey E.
A1 Craig, Michael D.
A1 Vey, Norbert
A1 Strickland, Stephen A.
A1 Schiller, Gary J.
A1 Jabbour, Elias
A1 Pigneux, Arnaud
A1 Horst, Heinz-August
A1 Récher, Christian
A1 Klimek, Virginia M.
A1 Cortes, Jorge E.
A1 Carella, Angelo-Michele
A1 Egyed, Miklos
A1 Krug, Utz
A1 Fox, Judith A.
A1 Craig, Adam R.
A1 Ward, Renee
A1 Smith, Jennifer A.
A1 Acton, Gary
A1 Kantarjian, Hagop M.
A1 Stuart, Robert K.
YR 2018
UL http://www.haematologica.org/content/103/11/e514.abstract
AB